ciprofloxacin

Generic: ciprofolxacin

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ciprofloxacin
Generic Name ciprofolxacin
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ciprofloxacin hydrochloride 250 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8875
Product ID 68788-8875_15755a35-e29a-47c1-89ab-e6645bb3ade9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208921
Listing Expiration 2026-12-31
Marketing Start 2025-05-19

Pharmacologic Class

Classes
cytochrome p450 1a2 inhibitors [moa] fluoroquinolone antibacterial [epc] fluoroquinolones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888875
Hyphenated Format 68788-8875

Supplemental Identifiers

RxCUI
197511
UNII
4BA73M5E37

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ciprofloxacin (source: ndc)
Generic Name ciprofolxacin (source: ndc)
Application Number ANDA208921 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 6 TABLET in 1 BOTTLE (68788-8875-0)
  • 14 TABLET in 1 BOTTLE (68788-8875-1)
  • 20 TABLET in 1 BOTTLE (68788-8875-2)
  • 30 TABLET in 1 BOTTLE (68788-8875-3)
  • 40 TABLET in 1 BOTTLE (68788-8875-4)
  • 60 TABLET in 1 BOTTLE (68788-8875-6)
  • 10 TABLET in 1 BOTTLE (68788-8875-8)
source: ndc

Packages (7)

Ingredients (1)

ciprofloxacin hydrochloride (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "15755a35-e29a-47c1-89ab-e6645bb3ade9", "openfda": {"unii": ["4BA73M5E37"], "rxcui": ["197511"], "spl_set_id": ["15755a35-e29a-47c1-89ab-e6645bb3ade9"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "6 TABLET in 1 BOTTLE (68788-8875-0)", "package_ndc": "68788-8875-0", "marketing_start_date": "20250519"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (68788-8875-1)", "package_ndc": "68788-8875-1", "marketing_start_date": "20250519"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-8875-2)", "package_ndc": "68788-8875-2", "marketing_start_date": "20250519"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8875-3)", "package_ndc": "68788-8875-3", "marketing_start_date": "20250519"}, {"sample": false, "description": "40 TABLET in 1 BOTTLE (68788-8875-4)", "package_ndc": "68788-8875-4", "marketing_start_date": "20250519"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-8875-6)", "package_ndc": "68788-8875-6", "marketing_start_date": "20250519"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (68788-8875-8)", "package_ndc": "68788-8875-8", "marketing_start_date": "20250519"}], "brand_name": "Ciprofloxacin", "product_id": "68788-8875_15755a35-e29a-47c1-89ab-e6645bb3ade9", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Fluoroquinolone Antibacterial [EPC]", "Fluoroquinolones [CS]"], "product_ndc": "68788-8875", "generic_name": "Ciprofolxacin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ciprofloxacin", "active_ingredients": [{"name": "CIPROFLOXACIN HYDROCHLORIDE", "strength": "250 mg/1"}], "application_number": "ANDA208921", "marketing_category": "ANDA", "marketing_start_date": "20250519", "listing_expiration_date": "20261231"}